Written Question · S3W-28541 · Session 3
Whether it plans to increase the number of facilities that can provide adult respiratory extracorporeal membrane oxygenation treatment.
The question
To ask the Scottish Executive whether it plans to increase the number of facilities that can provide adult respiratory extracorporeal membrane oxygenation treatment.
The answer
It is fundamental that anyone who might benefit from extracorporeal membrane oxygenation (ECMO) treatment has access to it. There are robust arrangements in place to ensure access to adult respiratory ECMO treatment through the UK''s nationally commissioned ECMO centre at Glenfield Hospital in Leicester, and, when it is full, at the European ECMO centre in Stockholm.
However, it is clear in the immediate term that H1N1 is having a significant impact on the demand for adult respiratory ECMO. That is why UK health ministers have agreed to double ECMO facilities at Glenfield Hospital to 10 beds, following recommendations by the UK Critical Care Group. Additional short term capacity has also been commissioned at the Royal Brompton and Papworth Hospitals in England which can provide a further four beds.
In Scotland, Aberdeen Royal Infirmary is the only site with both ECMO machines and a clinical team trained by Leicester to provide adult respiratory ECMO. When additional capacity is required, ECMO could therefore also be provided in Aberdeen, but only with the agreement and ongoing support and advice of Leicester clinicians on a case-by-case basis and in the context of the current H1N1 pandemic.
The potential medium and longer term needs for the provision of non-H1N1 adult respiratory ECMO in Scotland continues to be considered by the Expert Group set up for this purpose.
However, it is clear in the immediate term that H1N1 is having a significant impact on the demand for adult respiratory ECMO. That is why UK health ministers have agreed to double ECMO facilities at Glenfield Hospital to 10 beds, following recommendations by the UK Critical Care Group. Additional short term capacity has also been commissioned at the Royal Brompton and Papworth Hospitals in England which can provide a further four beds.
In Scotland, Aberdeen Royal Infirmary is the only site with both ECMO machines and a clinical team trained by Leicester to provide adult respiratory ECMO. When additional capacity is required, ECMO could therefore also be provided in Aberdeen, but only with the agreement and ongoing support and advice of Leicester clinicians on a case-by-case basis and in the context of the current H1N1 pandemic.
The potential medium and longer term needs for the provision of non-H1N1 adult respiratory ECMO in Scotland continues to be considered by the Expert Group set up for this purpose.
In the Official Report
No contribution in the Official Report cites S3W-28541 by reference.